Optimal Pathological Response After Neoadjuvant Chemotherapy for MIBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration
BJU Int 2021 Nov 01;128(5)607-614, P Ravi, GR Pond, LN Diamantopoulos, C Su, A Alva, RK Jain, WP Skelton, S Gupta, JD Tward, KM Olson, P Singh, CM Grunewald, G Niegisch, JL Lee, A Gallina, M Bandini, A Necchi, M Mossanen, BA McGregor, C Curran, P Grivas, GP SonpavdeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.